Prostate disease in older men: 2. Cancer
Hosp Pract (1995). 1997 Oct 15;32(10):159-66, 171, 175-6 passim.
doi: 10.1080/21548331.1997.11443584.
Affiliation
- 1 Division of Urology, University of Connecticut Health Center, Farmington, USA.
Abstract
Proof is lacking that early detection and treatment reduce mortality from prostate cancer. Indeed, many patients die with the tumor, not from it. In the absence of better data, the clinician must, when making treatment recommendations, weigh the biology of the disease, the potential morbidity of treatment, other factors that affect the patient's longevity, and the patient's attitude toward risk.
MeSH terms
-
Aged
-
Biopsy, Needle
-
Combined Modality Therapy
-
Humans
-
Life Expectancy
-
Male
-
Middle Aged
-
Neoplasm Staging
-
Prostate / pathology
-
Prostate-Specific Antigen / blood
-
Prostatic Neoplasms / diagnosis*
-
Prostatic Neoplasms / pathology
-
Prostatic Neoplasms / therapy
-
Risk Factors
Substances
-
Prostate-Specific Antigen